Silk Road Medical, Inc (SILK)

Silk Road Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-55.74	-55.01	-49.81	-47.33	-52.41
Depreciation & Amortization	3.79	3.17	1.92	1.39	1.29
Share-Based Compensation	38.89	25.02	14.61	7.23	2.98
Other Operating Activities	-18.96	-5.76	-5.66	-3.36	18.53
Operating Cash Flow	-32.01	-32.58	-38.94	-42.07	-29.61
Capital Expenditures	-1.51	-5.01	-4.76	-0.84	-0.54
Change in Investments	-5.67	-157.06	77.4	-8.55	-69.42
Investing Cash Flow	-7.18	-162.07	72.64	-9.39	-69.96
Share Issuance / Repurchase	3.89	114.79	6.95	75.74	111.97
Debt Issued / Paid	0	24.91	0	6.01	0
Other Financing Activities	-	-	0.03	-	1.78
Financing Cash Flow	3.89	139.7	6.98	81.75	113.76
Net Cash Flow	-35.3	-54.95	40.69	30.29	14.19
Free Cash Flow	-33.52	-37.59	-43.69	-42.91	-30.15
Free Cash Flow Margin	-18.92%	-27.11%	-43.06%	-57.04%	-47.58%
Free Cash Flow Per Share	-0.86	-1.05	-1.26	-1.30	-1.31

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).